- JP18th Edition [June 7, 2021, the MHLW Ministerial Notification No. 220]
- General Notice - General Tests,Processes and Apparatus [5,792KB]
- Official Monographs(A to L) [11,728KB]
- Official Monographs(M to Z) [8,481KB]
- Crude Drugs and Related Drugs [2,766KB]
- Infrared Reference Spectra [15,169KB]
- Ultraviolet-visible Reference Spectra [16,823KB]
- General Information [2,661KB]
Note: the links above all lead to the files on the MHLW website.
- JP18th Edition Errata [273KB] [Issued in June 3, 2022, September 14, 2022, November 10, 2023 and November 29, 2024]
- JP18th Edition Supplement l [3,286KB][December 12, 2022, the MHLW Ministerial Notification No. 355]
Note: the link lead to the file on the MHLW website.
- JP18th Edition Supplement I Errata [91.8KB] [Issued in July 17, 2024]
- JP18th Edition Supplement II [2.8MB] [June 28, 2024, the MHLW Ministerial Notification No. 238]
Note: the link lead to the file on the MHLW website.
| N.B.: The Japanese Pharmacopoeia Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia.（See the General Notices 5.） |